BioNews Clinical Will Bring Trials Into ‘Continuum’ of MS Care & Ed Tobias' 50th College Reunion
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare a...
22 Loka 202112min
i-Belong App Aims to Expand Online MS Patient Communities
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Belong.Life's, a new i-Belong app that allows health professionals, advocacy groups, pharmas and othe...
20 Loka 20216min
Combo of Biomarkers Predicts Future Disease Activity & John Connor Gets A New Hairstyle
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how high levels of neurofilament light chain (NfL) protein combined with thinning of the retina can b...
18 Loka 202114min
FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article, “FDA to Review ANI’s Request for Cortrophin Gel Use” and reads the column by Ed Tobias, MS Wire, “Amazon...
15 Loka 20218min
Early High-efficacy DMTs Linked to Better RRMS Outcomes in Sweden & Being Enough With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how early high-efficacy disease modifying therapies (DMTs) are linked to better outcomes in patients with Relapsing-Re...
13 Loka 20219min
Interferon Beta-1b Effective, Safe for Older MS Patients & John Connor's Latest Column
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Interferon Beta-1b, and it’s effectiveness and safety for older Multiple Sclerosis (MS) patients and reads the column ...
11 Loka 202112min
Moderate-To-Severe Bowel Problems Found in 14.5% Of People with MS & Ed Tobias’ Latest Column
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses moderate-to-severe bowel problems found in 14.5% of people with Multiple Sclerosis (MS) and reads the column by Ed Tob...
8 Loka 20215min
Landos Biopharma and Johns Hopkins School of Medicine Partner to Advance Oral Therapy
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Landos Biopharma and Johns Hopkins School of Medicine partnering to advance a potential Multiple Sclerosos (MS) oral t...
6 Loka 20218min
